Herbalife soars 70% since InvestingPro’s February Fair Value alert

InvestingPro's Fair Value model accurately identified Herbalife Ltd. (HLF) as significantly undervalued in February 2025, when the stock traded at $5.62 against a projected fair value of $8.66. By November 2025, HLF shares had surged 70% to $9.07, exceeding the model's initial upside projection, driven by fundamental improvements including increased EPS and EBITDA, credit rating upgrades from S&P Global and Moody's, consistent earnings beats, and positive analyst revisions. This performance underscores the efficacy of data-driven valuation analysis in uncovering substantial market opportunities for institutional investors.

Analysis

InvestingPro's Fair Value model accurately identified Herbalife Ltd. (HLF) as significantly undervalued in February 2025, when the stock traded at $5.62 against a projected fair value of $8.66, indicating 54% upside potential. This signal was issued despite HLF reporting $4.99 billion in revenue and $589.7 million in EBITDA, following six months of mostly negative stock returns.

By November 2025, HLF shares had surged 70% to $9.07, exceeding the model's initial projection, driven by robust fundamental improvements. The company reported EPS growth from $2.53 to $3.14 and an increase in EBITDA to $618.2 million, alongside a solid financial health score of 4.19.

Further validating the thesis, S&P Global upgraded Herbalife's credit rating due to successful deleveraging efforts, and Moody's revised its outlook to stable. Analyst sentiment also improved significantly, with DA Davidson doubling its price target to $14 and Citi setting a $13 target, reflecting consistent earnings beats and strategic moves into personalized nutrition.

Key Decisions for Investors

• Investors should consider integrating data-driven valuation models into their research process to identify potentially undervalued assets before broader market recognition.
• Focus on companies demonstrating tangible fundamental improvements, such as EPS and EBITDA growth, alongside successful deleveraging efforts, as these factors often precede positive market re-ratings.
• Monitor credit rating upgrades from agencies like S&P Global and Moody's, as well as significant positive revisions in analyst price targets, as these can signal strengthening company health and future stock performance.